New lab space coming to port’s Terminal One, first tenant announced

"AbsSci LLC, a rapidly-growing regional biotechnology company best known for its proprietary protein manufacturing platform, has signed a lease to occupy 6,200 square feet of the former Red Lion Hotel building at the Quay, on the Port of Vancouver’s Terminal One property...

Prior to AbSci moving in, the port plans to renovate a portion of the former hotel into the first dedicated life sciences technology lab space in Southwest Washington. According to the port, the new space – named the Columbia River Life Sciences Technology Building – will give AbSci the flexibility to expand while greatly increasing the region’s ability to attract additional companies in the biotech sector.

“With the company’s growth, we needed to find a home that would allow us to continue to expand,” said AbSci CEO Sean McClain. “We are excited to be the first tenant of this new facility, and we believe there will be a great deal of demand for this space from companies similar to ourselves.”

AbSci, founded in Portland in 2011, recently hired its tenth employee and projects to expand to 50 employees by 2020. The company’s technology reduces the production costs of therapeutic proteins and antibodies, which are used in a wide range of medical treatment plans."